Abiopharma

News list

Kang Daniel 🟢 acquired 13.0K shares of DeFi Development Corp. (DFDV) at $2.91 Transaction Date: Aug 14, 2026 | Filing ID: 007140

Full text

News bot Aug. 17, 2026, 8:49 p.m.
🔍 Kang Daniel (Executive)

Company: DeFi Development Corp. (DFDV)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 2
- Total shares acquired: 13,000
- Total shares held: 54,033
Detailed Transactions and Holdings:
- Acquired 13,000 shares of Common Stock at $2.91 per share (Direct)
  Date: 2026-08-14 | Code: P | equity_swap_involved: 0 | shares_owned_after: 13,000.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | shares_owned_after: 7,181.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: By Defi Dev LLC | shares_owned_after: 46,852.00 | Footnotes: F2
Footnotes:
- F1: Mr. Kang is the sole member and manager of Riveya Technology Fund LLC.
- F2: Mr. Kang is a member of Defi Dev LLC, a manager-managed limited liability company. The securities herein are voted by Parker White serving as manager of Defi Dev LLC.